Remove 2022 Remove Compounding Remove FDA
article thumbnail

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). 1 The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients. Sign up today for our free Drug Topics newsletter.

FDA
article thumbnail

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Drug Topics

In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. million adult patients who were enrolled in a health plan as of January 2022 that contributed data to the Optum database. Of those, 38% had evidence of pneumococcal vaccination prior to January 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacist Involvement Helps Reduce Time to A1c Target

Drug Topics

In 2022, the estimated cost of those diagnosed as having diabetes was $413 billion. 2022 Jun 20;15:1911-1923. Additional advantages include fewer emergency visits, hospitalizations, medication adherence, and associated cost savings. 2 “Prevalence of diabetes in the United States continues to rise, affecting an estimated 38.4

article thumbnail

What to know before buying compounded semaglutide online

The Checkup by Singlecare

Food and Drug Administration (FDA), such as Rybelsus (oral semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), and Saxenda (liraglutide). Compounded semaglutide is another option, and its lower cost may make it seem like an appealing alternative. What are compounding pharmacies?

article thumbnail

CGM Usage Improves Glycemic, Psychosocial Outcomes for Type 1 Diabetes | ADA 2025

Drug Topics

Updated September 12, 2022. June 20 to 23, 2025. Chicago, Illinois. Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD). ClinicalTrials.gov identification: NCT04161131. Accessed June 23, 2025.

article thumbnail

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

Daymon, 2022 Private Brand Intelligence Report, May 2023. Our team will be on site to share insights and showcase our portfolio of more than 500 health and wellness OTC products through the Foster & Thrive brand name, including affordable and eco-friendly offerings that reflect today’s consumer priorities. Fred Reichheld. April 2025.

article thumbnail

Mounjaro generic availability, cost, and more

The Checkup by Singlecare

Mounjaro (tirzepatide) is a brand-name prescription medication that is approved by the Food and Drug Administration (FDA) to improve blood sugar levels in people with Type 2 diabetes. The FDA recently approved generic versions of two other GLP-1s , Victoza (liraglutide) and Byetta (exenatide). Is there a generic for Mounjaro?